New Infestin-4 Mutants with Increased Selectivity against Factor XIIa

• Vladimir N. Kolyadko ,

  Contributed equally to this work with: Vladimir N. Kolyadko, Sofya V. Lushchekina

  Affiliation Center for Theoretical Problems of Physicochemical Pharmacology of Russian Academy of Sciences, Moscow, Russian Federation

  ⨯
• Sofya V. Lushchekina ,

  Contributed equally to this work with: Vladimir N. Kolyadko, Sofya V. Lushchekina

  Affiliation Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, Moscow, Russian Federation

  ⨯
• Tatiana A. Vuimo,

  Affiliation Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev of Ministry of Health, Moscow, Russian Federation

  ⨯
• Stepan S. Surov,

  Affiliation Center for Theoretical Problems of Physicochemical Pharmacology of Russian Academy of Sciences, Moscow, Russian Federation

  ⨯
• Ruzanna A. Ovsepyan,

  Affiliation Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev of Ministry of Health, Moscow, Russian Federation

  ⨯
• Vera A. Korneeva,

  Affiliation Center for Theoretical Problems of Physicochemical Pharmacology of Russian Academy of Sciences, Moscow, Russian Federation

  ⨯
• Ivan I. Vorobiev,

  Affiliation Center “Bioengineering” of Russian Academy of Sciences, Moscow, Russian Federation

  ⨯
• Nadezhda A. Orlova,

  Affiliation Center “Bioengineering” of Russian Academy of Sciences, Moscow, Russian Federation

  ⨯
• Leonid Minakhin,

  Affiliation Waksman Institute of Microbiology, Rutgers The State University of New Jersey, Piscataway, New Jersey, United States of America

  ⨯
• Konstantin Kuznedelov,

  Affiliation Waksman Institute of Microbiology, Rutgers The State University of New Jersey, Piscataway, New Jersey, United States of America

  ⨯
• Konstantin V. Severinov,

  Affiliation Waksman Institute of Microbiology, Rutgers The State University of New Jersey, Piscataway, New Jersey, United States of America

  ⨯
• Fazoil I. Ataullakhanov,

  Affiliations Center for Theoretical Problems of Physicochemical Pharmacology of Russian Academy of Sciences, Moscow, Russian Federation, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev of Ministry of Health, Moscow, Russian Federation, Department of Physics, Lomonosov Moscow State University, Moscow, Russian Federation, Faculty of Biological and Medical Physics, Moscow Institute of Physics and Technology, Dolgoprudny, Russian Federation, HemaCore LLC., Moscow, Russian Federation

  ⨯
• Mikhail A. Panteleev

  * E-mail: mapanteleev@yandex.ru

  Affiliations Center for Theoretical Problems of Physicochemical Pharmacology of Russian Academy of Sciences, Moscow, Russian Federation, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev of Ministry of Health, Moscow, Russian Federation, Department of Physics, Lomonosov Moscow State University, Moscow, Russian Federation, Faculty of Biological and Medical Physics, Moscow Institute of Physics and Technology, Dolgoprudny, Russian Federation, HemaCore LLC., Moscow, Russian Federation

  ⨯